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The use of vaginal microbicides has gained support as a
strategy for the protection of women against HIV-1 and
other sexually transmitted disease (STD) pathogens. The
preclinical Swiss Webster murine model has been devel-
oped to specifically measure cervicovaginal tissue integrity
and inflammation following application of candidate
vaginal microbicides, when potential exposure to an STD
pathogen may occur. This model demonstrates both
mechanistic and temporal differences in inflammatory
responses following microbicide exposure. Currently, spe-
cific markers of inflammation, including pro-inflamma-
tory cytokines, are being evaluated in the cervicovaginal
mucosa. Safety profiles of polybiguanides (PBGs), which
demonstrated significant in vitro efficacy against HIV-1,
are being assessed in vivo. Intravaginal application of
PEHMB (1%) resulted in little or no cervicovaginal toxic-
ity after short- or long-term exposure. Collectively, these
studies support the Swiss Webster model as a valuable
tool for the preclinical assessment of toxicity and inflam-
mation associated with exposure to candidate topical
microbicides. Furthermore, these results strongly support
further development of polybiguanide derivatives as vagi-
nal microbicidal agents.
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